Occudo Quantitative Strategies LP Prothena Corp Public LTD CO Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$47.3 - $70.6 $247,047 - $368,743
5,223 New
5,223 $252,000
Q1 2023

May 15, 2023
SELL
$46.97 - $58.27 $383,697 - $476,007
-8,169 Reduced 63.01%
4,796 $232,000
Q4 2022

Feb 14, 2023
SELL
$52.05 - $65.0 $1.35 Million - $1.69 Million
-25,924 Reduced 66.66%
12,965 $781,000
Q3 2022

Nov 14, 2022
BUY
$25.16 - $60.63 $978,447 - $2.36 Million
38,889 New
38,889 $2.36 Million

Others Institutions Holding PRTA

# of Institutions
184
Shares Held
42.7M
Call Options Held
162K
Put Options Held
102K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $714M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email